Nivolumab vs Rivaroxaban

## Nivolumab vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Rivaroxaban**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Rivaroxaban**: Direct Factor Xa inhibitor.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Rivaroxaban — 5-9 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Rivaroxaban — C19H18ClN3O5S.

**Molecular Weight**: Nivolumab — N/A; Rivaroxaban — 435.8820 g/mol.

**Type**: Nivolumab — Antibody; Rivaroxaban — Small molecule.